Online first
Review paper
Published online: 2025-03-21
Current approach to the use of transvaginal mesh systems in pelvic organ prolapse
1, 1, 1
, 1, 1
, 1, 1
DOI: 10.5603/gpl.101432
Pubmed: 40145699
Abstract
Pelvic organ prolapse (POP) involves the descent of vaginal walls, uterus, or vaginal apex. Traditional native tissue repair techniques, while low in complications, exhibit significant relapse rates. To enhance durability of surgical repair, synthetic mesh systems were adopted. However, early generations faced complications such as vaginal mesh exposure and dyspareunia, leading to critical reevaluation and regulatory actions.
The Food and Drug Administration issued first warning in 2008 and reclassified mesh as high-risk in 2016, banning it for transvaginal anterior compartment prolapse in 2019. European and Canadian regulations similarly increased scrutiny, with prominent professional organizations and regulatory bodies endorsing limited use and thorough counseling.
Subsequent innovations introduced lighter mesh systems with sacrospinous ligament fixation, which improved anatomical outcomes and reduced adverse effects. Recent studies on these systems demonstrate promising success rates, with notable reductions in prolapse recurrence and improved quality of life.
Given these developments, current perspectives advocate for selective use of advanced mesh systems in POP surgery, emphasizing rigorous patient selection, informed consent, and meticulous surgical technique. This careful approach, as opposed to a categorical ban, aims to balance the therapeutic benefits with potential risks, ensuring optimized patient outcomes in POP management.
Keywords: pelvic organ prolapsetransvaginal mesh repairsacrospinous ligament fixation
References
- Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016; 27(2): 165–194.
- Hagen S, Stark D. Conservative prevention and management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2011(12): CD003882.
- Maher C, Feiner B, Baessler K, et al. Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse. Cochrane Database Syst Rev. 2016; 2(2): CD012079.
- Larouche M, Geoffrion R, Walter JE. No. 351-Transvaginal Mesh Procedures for Pelvic Organ Prolapse. J Obstet Gynaecol Can. 2017; 39(11): 1085–1097.
- Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2015; 27(7): CD006375.
- Bako A, Dhar R. Review of synthetic mesh-related complications in pelvic floor reconstructive surgery. Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20(1): 103–111.
- Larouche M, Merovitz L, Correa JA, et al. Outcomes of trocar-guided Gynemesh PS™ versus single-incision trocarless Polyform™ transvaginal mesh procedures. Int Urogynecol J. 2015; 26(1): 71–77.
- Hiltunen R, Nieminen K, Takala T, et al. Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial. Obstet Gynecol. 2007; 110(2 Pt 2): 455–462.
- Lim YN, Rane A, Muller R. An ambispective observational study in the safety and efficacy of posterior colporrhaphy with composite Vicryl-Prolene mesh. Int Urogynecol J Pelvic Floor Dysfunct. 2005; 16(2): 126–131; discussion 131.
- Withagen MI, Vierhout ME, Hendriks JC, et al. Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure. Obstet Gynecol. 2011; 118(3): 629–636.
- Sokol AI, Iglesia CB, Kudish BI, et al. One-year objective and functional outcomes of a randomized clinical trial of vaginal mesh for prolapse. Am J Obstet Gynecol. 2012; 206(1): 86.e1–86.e9.
- Feiner B, O'Rourke P, Maher C. A prospective comparison of two commercial mesh kits in the management of anterior vaginal prolapse. Int Urogynecol J. 2012; 23(3): 279–283.
- Baessler K, Maher CF. Mesh augmentation during pelvic-floor reconstructive surgery: risks and benefits. Curr Opin Obstet Gynecol. 2006; 18(5): 560–566.
- Lim YN, Muller R, Corstiaans A, et al. A long-term review of posterior colporrhaphy with Vypro 2 mesh. Int Urogynecol J Pelvic Floor Dysfunct. 2007; 18(9): 1053–1057.
- Milani R, Salvatore S, Soligo M, et al. Functional and anatomical outcome of anterior and posterior vaginal prolapse repair with prolene mesh. BJOG. 2005; 112(1): 107–111.
- Lee D, Dillon B, Lemack G, et al. Transvaginal mesh kits—how "serious" are the complications and are they reversible? Urology. 2013; 81(1): 43–48.
- Dunn GE, Hansen BL, Egger MJ, et al. Changed women: the long-term impact of vaginal mesh complications. Female Pelvic Med Reconstr Surg. 2014; 20(3): 131–136.
- US Food and Drug Administration. FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. October 20, 2008. https://www.govinfo.gov/content/pkg/USCOURTS-ca4-15-01454/pdf/USCOURTS-ca4-15-01454-1.pdf.
- U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-takes-action-protect-womens-health-orders-manufacturers-surgical-mesh-intended-transvaginal.
- MHRA, Medicines and Healthcare Products Regulatory Agency. A summary of the evidence on the benefits and risks of vaginal mesh implants. 2014. https://www.gov.uk/government/publications/vaginal-mesh-implants-summary-of-benefits-and-risks, Accessed Nov 2014.
- NICE Guidance - Urinary incontinence and pelvic organ prolapse in women: management: © NICE (2019) Urinary incontinence and pelvic organ prolapse in women: management. BJU Int. 2019; 123(5): 777–803.
- Kuszka A, Brandt A, Niesel A, et al. 3 Year outcome after treatment of uterovaginal prolapse with a 6-point fixation mesh. Eur J Obstet Gynecol Reprod Biol. 2020; 255: 160–164.
- Cadenbach-Blome T, Grebe M, Mengel M, et al. Significant improvement in quality of life, positive effect on sexuality, lasting reconstructive result and low rate of complications following cystocele correction using a lightweight, large-pore, titanised polypropylene mesh: final results of a national, multicentre observational study. Geburtshilfe Frauenheilkd. 2019; 79(9): 959–968.
- Fünfgeld C, Stehle M, Henne B, et al. Quality of life, sexuality, anatomical results and side-effects of implantation of an alloplastic mesh for cystocele correction at follow-up after 36 months. Geburtshilfe Frauenheilkd. 2017; 77(9): 993–1001.
- Farthmann J, Mengel M, Henne B, et al. Improvement of pelvic floor-related quality of life and sexual function after vaginal mesh implantation for cystocele: primary endpoint of a prospective multicentre trial. Arch Gynecol Obstet. 2016; 294(1): 115–121.
- Huang KH, Chen WH, Yang TH, et al. Comparison of prolift, perigee-apogee, prosima, and elevate transvaginal mesh systems in pelvic organ prolapse surgery: clinical outcomes of a long-term observational study. Low Urin Tract Symptoms. 2022; 14(1): 47–56.
- Moore RD, Mitchell GK, Miklos JR. Single-incision vaginal approach to treat cystocele and vault prolapse with an anterior wall mesh anchored apically to the sacrospinous ligaments. Int Urogynecol J. 2012; 23(1): 85–91.
- Huang KH, Huang LY, Chu LC, et al. Evaluation of the single-incision Elevate system to treat pelvic organ prolapse: follow-up from 15 to 45 months. Int Urogynecol J. 2015; 26(9): 1341–1346.
- Faioli R, Sozzi G, Chiantera V, et al. Anterior/Apical single incision mesh (Elevate™): Surgical experience, anatomical and functional results, and long-term complications. Eur J Obstet Gynecol Reprod Biol. 2021; 260: 166–170.
- Rogowski A, Kluz T, Szafarowska M, et al. Efficacy and safety of the Calistar and Elevate anterior vaginal mesh procedures. Eur J Obstet Gynecol Reprod Biol. 2019; 239: 30–34.
- Daniel W, Valerie To, Alan L. Ten-year surgical complications and mesh erosion of transvaginal Elevate™ mesh for management of pelvic organ prolapse. J Obstet Gynaecol. 2022; 42(6): 2354–2359.
- Hsieh HY, Tsai CP, Liu CK, et al. Factors that affect outcomes of prolapse repair using single-incision vaginal mesh procedures. Neurourol Urodyn. 2018; 37(1): 298–306.
- Levy G, Padoa A, Fekete Z, et al. Self-retaining support implant: an anchorless system for the treatment of pelvic organ prolapse-2-year follow-up. Int Urogynecol J. 2018; 29(5): 709–714.
- Levy G, Padoa A, Marcus N, et al. Surgical treatment of advanced anterior wall and apical vaginal prolapse using the anchorless self-retaining support implant: long-term follow-up. Int Urogynecol J. 2022; 33(11): 3067–3075.
